Nikhil Chopra, India Business Head, Cipla speaks on busting myths on asthma and Ciplas' #BerokZindagi initiative to lead a better life in a conversation with Prabhat Prakash
What is the incidence rate of asthma in India? How huge is the disease burden?
In India, 93 million people suffer from chronic respiratory diseases, of which 38 million people are diagnosed as asthmatics. One must note that these chronic respiratory diseases cause the second largest mortality after cardiovascular diseases. (Source: https:// www.thelancet.com/journals/lan glo/article/PIIS2214109X(18)30409-1/fulltext) Doctors across the nation see an average of around 30-40 patients suffering from respiratory diseases like asthma on a daily basis, and there is absolutely no sign of reduction of the disease burden. In fact, last year saw a whopping 25 per cent increase in the number of people suffering from respiratory symptoms compared to the previous year. It is estimated that one-third of the population will develop asthma at some point, and mostly before the age of 20. Factors such as the rise of particulate matter in the air, pollen, smoking, food habits, nutritional deficiency, hereditary predisposition and largely ignorance amongst parents only increase the prevalence of the disease.
As asthma is a chronic disease it poses a lot of economic burden on the patient. Is cost a deterrent?
Higher initial costs tend to hinder the adoption of consistent therapy for asthma in the lower socio-economic groups. However, if one considers the price bracket of inhalers which is the mainstay for treatment, a patient needs to shell out a daily cost of less than ̀ 10. Also, the range of solutions that we offer for asthma in India is not available anywhere else at such accessible prices. Hence, we can say that in terms of reasons for not adopting inhalation therapy for asthma, the lack of awareness and prevailing misconceptions about it far surpass the factor of cost burden for non-adoption.
この記事は Express Pharma の March 01-15, 2019 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Express Pharma の March 01-15, 2019 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation